Literature DB >> 27126132

Nuss procedure for pectus excavatum in adults: long-term results in a prospective observational study.

Beatrix Hoksch1, Gregor Kocher2, Philippe Vollmar2, Fabien Praz3, Ralph Alexander Schmid2.   

Abstract

OBJECTIVES: Since the end of the 1990s, the management of pectus excavatum has undergone major changes. The Nuss procedure (pectus bar) has been the method of choice for patients with pectus excavatum at Bern University Hospital for over a decade. The current study will describe our experiences, with a particular focus on long-term results in adults.
METHODS: The prospective observational study began in autumn 2002. The Haller index was used to quantify pectus excavatum severity. Pulmonary function tests and cardiac examinations were performed preoperatively, and a standardized management for surgical techniques and for the pre- and postoperative treatments including long-term follow-up at 3, 12 and 36 months after surgery was developed. Quality of life and satisfaction with the cosmetic result after the Nuss procedure were evaluated.
RESULTS: Better or much better quality of life after the Nuss procedure was observed: n = 108 (88.4%) at 3 months, n = 97 (89.0%) at 12 months and n = 87 (92.5%) at 36 months. Pain intensity decreased in the follow-up [pain score visual analogue scale (VAS) at 3 months: median 1 (0-7), 12 months: median 1 (0-4), 36 months: median 0.8 (0-5)]. After long-term observation, over 90% of patients described their quality of life after the operation as being better or much better. Satisfaction with the cosmetic results of the operation was also very high, with >90% of patients being satisfied. Only a very small group of patients suffered from pain in the long-term follow-up. Complications were rare (14.7%) and could be treated in most cases without reoperation.
CONCLUSION: Our results demonstrate that the Nuss procedure is safe and can be performed with excellent results in adults, both in the short term and in the long term. The improved quality of life and patients' satisfaction with cosmetic results remained high in the long-term follow-up, 10 years after the surgical procedure.
© The Author 2016. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  MIRPE; Nuss procedure; Pectus Bar; Pectus excavatum

Mesh:

Year:  2016        PMID: 27126132     DOI: 10.1093/ejcts/ezw130

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  Nuss Technique for Pectus Excavatum in Adult Patients: Cosmetic Satisfaction and Improvement of Quality of Life in a Single-Center Experience.

Authors:  Domenico Viggiano; Stefano Bongiolatti; Sara Borgianni; Roberto Lo Piccolo; Luca Voltolini; Alessandro Gonfiotti
Journal:  Front Surg       Date:  2022-06-01

2.  Improvement in Polysomnographic Objective Sleep Quality in Adults with Pectus Excavatum After the Nuss Procedure.

Authors:  Mei-Chen Yang; Chou-Chin Lan; Yao-Kuang Wu; Min-Shiau Hsieh; Bo-Chun Wei; Yeung-Leung Cheng
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

3.  Cardiopulmonary Outcomes After the Nuss Procedure in Pectus Excavatum.

Authors:  Dawn E Jaroszewski; Juan M Farina; Michael B Gotway; Joshua D Stearns; Michelle A Peterson; Venkata S K K Pulivarthi; Peter Bostoros; Ahmad S Abdelrazek; Ashwini Gotimukul; David S Majdalany; Courtney M Wheatley-Guy; Reza Arsanjani
Journal:  J Am Heart Assoc       Date:  2022-04-04       Impact factor: 5.501

Review 4.  Outcomes in adult pectus excavatum patients undergoing Nuss repair.

Authors:  MennatAllah M Ewais; Shivani Chaparala; Rebecca Uhl; Dawn E Jaroszewski
Journal:  Patient Relat Outcome Meas       Date:  2018-01-30

5.  Clinical application of enhanced recovery after surgery (ERAS) in pectus excavatum patients following Nuss procedure.

Authors:  Pingwen Yu; Gebang Wang; Chenlei Zhang; Hongxi Liu; Yawei Wang; Zhanwu Yu; Hongxu Liu
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.